Your selection

Innovation / 23.05.2025
Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time

Eckert & Ziegler SE (ISIN DE0005659700) has once again been honored with the “Best Managed Companies Award”. The award, presented by Deloitte Private, UBS, the Frankfurter Allgemeine Zeitung and the Federation of German Industries (BDI), recognize excellently managed medium-sized companies throughout Germany. Eckert & Ziegler has now received this coveted award the second time.

The award is the result of a comprehensive, multi-stage application process in which companies are assessed for their excellence in the core areas of strategy, productivity and innovation, culture and commitment as well as finance and governance. A consistently high level of performance in all four categories is a prerequisite for selection. The final decision is made by an independent jury made up of renowned experts from business, science and the media.

“We are proud to once again receive the “Best Managed Companies Award,” says Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE. " The award encourages us to continue expanding our leading position as a supplier of isotopes for nuclear medicine and measurement technology. I would like to thank our more than 1,000 employees worldwide who have contributed significantly to this success.”

“Strategic foresight and innovative strength are the key characteristics of a Best Managed Company such as Eckert & Ziegler. The award winners navigate the constantly changing market conditions with foresight, set trends in a dynamic environment, and shape the future with the necessary caution. Eckert & Ziegler demonstrates how companies in their region can make a significant contribution to development and open up new perspectives for the economy and society,” emphasizes Dr. Christine Wolter, Partner and Lead at Deloitte Private.

About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
 

Source: Pressemitteilung Eckert & Ziegler SE
Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time

Overview News

News Buch Berlin

OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA

OMEICOS, a late-stage clinical biopharmaceutical company developing first-in-class small-molecule therapeutics for mitochondrial and inflammatory disorders, today announced the successful completion o...

more ...

A single cocaine dose alters mouse brain cells

Researchers led by Ana Pombo have found that just one exposure to the drug can create changes in mouse brain cells that persist for at least two weeks. Their findings were presented at the Federation ...

more ...

How the skin distinguishes cool from warm

Researchers in the lab of James Poulet have uncovered how the nervous system senses cool and warm temperatures. The findings, published in ​“Neuron” challenge a long-standing view of temperature sensi...

more ...

Events Buch Berlin

31.07.2026, 15:00
Ferienprogramm in der Stadtbibliothek: Experimente zum Thema Fliegen

Entdecke die Geheimnisse des Fliegens!

more ...

01.08.2026, 15:00
Gartengalerie Karow

Das Künstlerpaar Marion Friedrich (Malerei) und Dirk Motzkus (Skulpturen) öffnen ihre künstlerische Werkstatt für Interessierte

more ...

05.08.2026, 18:00
Bucher Stammtisch: "Verkehrswendebeziehungen & öffentlicher Raum"

This website is supported by: